Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Paradigm reshapes leadership structure as Patient Square acquisition approaches and workers’ compensation strategy expands Paradigm reshuffles leadership ahead of its Patient Square Capital acquisition. Discover what the changes signal for workers’ compensation and healthcare cost management. bySrinathMarch 5, 2026